Reported 2026-07-10Lot GT30-072026-199.89% purity · Vial 1: 31.76 mg, Vial 2: 32.59 mg (Average: 32.18 mg)
Open COA
Lyophilized Peptides
Tirzepatide Research Reference — 30 mg
Catalog material presented by identity, format, availability and applicable lot documentation for qualified laboratory procurement.
CatalogGT-PW-30MG
SourceSee lot documentation
FormatLyophilized Peptides
StatusAvailable
$210.00 Current catalog price; lot availability controls fulfillment.
AvailabilityIn stock
7451 in stock
Current product record, labeling and lot documentation control intended use and handling.
Tirzepatide Research Reference — 30 mg$210.00
01Lot documentationCOA and analytical-record model
02Defined specificationMethod and result remain lot specific
03Tracked fulfillmentShipping method and lot allocation confirmed at order review
04Responsible useNon-clinical laboratory context
Lot documentation
Current Certificate of Analysis
16 approved certificates are attached to this product record.
Reported 2026-07-10Lot GT30-072026-199.89% purity · Vial 1: 31.76 mg, Vial 2: 32.59 mg (Average: 32.18 mg)
Open COA
Reported 2026-07-10Lot GT30-072026-199.89% purity
Open COA
Reported 2026-06-07Lot GT30-AS-062026-499.95% purity · 33.43 mg
Open COA
Reported 2026-06-07Lot GT30-A5-062026-499.95% purity · 33.43 mg
Open COA
Reported 2026-03-22Lot GT30-032026-499.62% purity · 32.22 mg
Open COA
Reported 2026-03-22Lot GT30-032026-499.62% purity · 32.22 mg
Open COA
Reported 2026-02-05Lot GT30-020202699.515% purity · 29.66 mg
Open COA
Reported 2026-01-31Lot 3149599.8275% purity · 34.37 mg
Open COA
Reported 2025-12-29Lot GLP-TZ99.95% purity · 33.95 mg
Open COA
Reported 2025-12-19Lot GT30-12173025-H99.942% purity · 31.15 mg
Open COA
Reported 2025-12-17Lot GT36-9948299.919% purity · 31.36 mg
Open COA
Reported 2025-11-16Lot GT30-11132025-J99.967% purity · 31.97 mg
Open COA
Reported 2025-10-11Lot TIR3010032025-1899.987% purity · 33.10 mg
Open COA
Reported 2025-10-11Lot TIR3010032025-1899.987% purity
Open COA
Reported 2025-08-13Lot GT30-08112025-J99.9% purity · 30.09 mg
Open COA
Technical information
Record at a glance
- Primary catalog
- Lyophilized Peptides
- Product type
- Simple product
- Availability
- Available
- Lot control
- Current lot documentation and approved product record control
- Catalog number
- GT-PW-30MG
Intended laboratory context
Illustrative applications
- Evaluation within the lawful context identified by the current product record
- Lot-specific documentation review before procurement or laboratory use
Documentation package
Documentation
- PDFCertificate of Analysis / lot recordSample
- PDFProduct data or handling recordSample
- PDFSupporting product media archiveSample
Intended use, handling, storage and limitations are controlled by the current product record, labeling and applicable lot documentation. No dosing or medical guidance is provided.
Need a current record?
Documentation before decision-making.
Reference GT-PW-30MG and the applicable lot when contacting technical support. Published files support evaluation but do not replace the approved lot COA or material specification.
View documentation model